A Phase II Study Of Tirapazamine (NSC-130181)/Cisplatin/Etoposide And Concurrent Thoracic Radiotherapy For Limited Stage Small Cell Lung Cancer.

Trial Profile

A Phase II Study Of Tirapazamine (NSC-130181)/Cisplatin/Etoposide And Concurrent Thoracic Radiotherapy For Limited Stage Small Cell Lung Cancer.

Completed
Phase of Trial: Phase II

Latest Information Update: 09 Dec 2015

At a glance

  • Drugs Tirapazamine (Primary) ; Cisplatin; Etoposide
  • Indications Small cell lung cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 18 Jul 2012 Actual patient number changed from 85 to 72 as reported by ClinicalTrials.gov.
    • 08 Jun 2011 Actual end date changed from Jan 2009 to Aug 2009 as reported by ClinicalTrials.gov.
    • 11 Sep 2009 New source identified and integrated (Barbara Ann Karmanos Cancer Institute; S0222)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top